Predictive and prognostic value of circulating tumor cell detection in lung cancer : a clinician's perspective

Annette Tognela, Kevin J. Spring, Therese Becker, Nicole J. Caixeiro, Victoria J. Bray, Po Yee Yip, Wei Chua, Stephanie H. Lim, Paul de Souza

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)

Abstract

There is increasing evidence for the use of circulating tumor cells (CTCs) as a "liquid biopsy" for early detection of lung cancer recurrence, prognosticating disease and monitoring treatment response. Further, CTC molecular analysis and interrogation of single cells hold significant potential in providing insights into tumor biology and the metastatic process. Ongoing research will likely see the translation of CTCs as a prognostic and predictive biomarker in both small cell, and non-small cell, lung cancer to routine clinical practice.
Original languageEnglish
Pages (from-to)90-102
Number of pages13
JournalCritical Reviews in Oncology/Hematology
Volume93
Issue number2
DOIs
Publication statusPublished - 2015

Keywords

  • biomarkers
  • circulating tumour cells
  • lung cancer

Fingerprint

Dive into the research topics of 'Predictive and prognostic value of circulating tumor cell detection in lung cancer : a clinician's perspective'. Together they form a unique fingerprint.

Cite this